Nuvisan Pharma Services Selects ALPHADAS To Accelerate Clinical Development Processes
6/12/2014 8:24:36 AM
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that NUVISAN Pharma Services (“NUVISAN”) has purchased the ALPHADAS® clinical trials software solution suite for deployment in its Phase I unit located in Neu-Ulm, Germany.
Help employers find you! Check out all the jobs and post your resume.
comments powered by